Is taking a cabergoline pill during weaning effective in restoring milk supply?

Cabergoline (Cabergoline) is an oral dopamine receptor agonist. It mainly inhibits the secretion of prolactin (PRL) from the anterior pituitary gland, thereby reducing mammary gland stimulation signals and inhibiting lactation or milk return. Among women who are weaned or need to terminate breastfeeding, cabergoline is widely used because of its fast onset, short course of treatment, and good tolerance. It is one of the commonly used clinical milk restoration drugs.

Research shows that when taking a standard dose of cabergoline (usually 0.5 mg) during weaning, most women can experience a significant reduction in milk secretion within 24–48 hours. A single dose can quickly suppress prolactin levels, avoid breast tenderness and milk retention, have a short onset of effect and are easy for patients to operate.

The milk-returning effect of cabergoline may be affected by individual differences, including mammary gland maturity, duration of lactation, baseline prolactin level, and duration of medication. For patients who are breastfeeding for a long time or have a large amount of milk secretion, a single drug may return milk slightly slowly, but it can still significantly reduce milk secretion in the short term. If the effect is incomplete, the dosage can be adjusted under the guidance of a doctor or supplemented with physical intervention (such as hot compress, reducing breast stimulation).

You should follow your doctor's instructions when taking cabergoline, be careful to avoid conflicts with high blood pressure or heart disease medications, and be aware of possible mild side effects such as headache, dizziness, nausea, or low blood pressure. Usually, a single dose can achieve the goal of milk return, and long-term use is not required. Reasonable use of cabergoline can not only quickly restore milk, but also effectively reduce breast discomfort and improve weaning safety and comfort.

Reference materials:https://www.drugs.com/